ArticleMaterials today. Bio2026

Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

Youngri Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.